Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients

This study is ongoing, but not recruiting participants.

Study NCT00144300 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: September 2, 2005 Last Updated: October 12, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)